Screening for OPTN mutations in a cohort of British amyotrophic lateral sclerosis patients

Neurobiology of Aging

Volumn 33, Issue 12, 2012, Pages 2948.e15-2948.e17

  Johnson, Lauren ^a   Miller, Jack W ^a   Gkazi, Athina Soragia ^a   Vance, Caroline ^a   Topp, Simon D ^a   Newhouse, Stephen J ^a   Al Chalabi, Ammar ^a   Smith, Bradley N ^a   Shaw, Christopher E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Familial ALS; Motor neurone disease; Mutation; Optineurin gene; OPTN

Indexed keywords

OPTINEURIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRITISH; ETHNIC GROUP; EXON; GENE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; OPTINEURIN GENE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84866757247     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.06.023     Document Type: Article

References (14)

1. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
2. Belzil V.V., Daoud H., Desjarlais A., Bouchard J.P., Dupré N., Camu W., Dion P.A., Rouleau G.A. Analysis of OPTN as a causative gene for amyotrophic lateral sclerosis. Neurobiol. Aging 2011, 32:e13-e14.
3. Del Bo R., Tiloca C., Pensato V., Corrado L., Ratti A., Ticozzi N., Corti S., Castellotti B., Mazzini L., Sorarù G., Cereda C., D'Alfonso S., Gellera C., Comi G.P., Silani V. Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 2011, 82:1239-1243. SLAGEN Consortium.
4. Hortobágyi T., Troakes C., Nishimura A.L., Vance C., van Swieten J.C., Seelaar H., King A., Al-Sarraj S., Rogelj B., Shaw C.E. Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders. Acta Neuropathol 2011, 121:519-527.
5. Iida A., Hosono N., Sano M., Kamei T., Oshima S., Tokuda T., Kubo M., Nakamura Y., Ikegawa S. Optineurin mutations in Japanese amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 2012, 83:233-235.
6. Iida A., Hosono N., Sano M., Kamei T., Oshima S., Tokuda T., Nakajima M., Kubo M., Nakamura Y., Ikegawa S. Novel deletion mutations of OPTN in amyotrophic lateral sclerosis in Japanese. Neurobiol Aging 2012, 33:1843.e19-1843.e24.
7. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., Komure O., Matsuura S., Kobatake K., Morimoto N., Abe K., Suzuki N., Aoki M., Kawata A., Hirai T., Kato T., Ogasawara K., Hirano A., Takumi T., Kusaka H., Hagiwara K., Kaji R., Kawakami H. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010, 465:223-226.
8. Millecamps S., Boillée S., Chabrol E., Camu W., Cazeneuve C., Salachas F., Pradat P.F., Danel-Brunaud V., Vandenberghe N., Corcia P., Le Forestier N., Lacomblez L., Bruneteau G., Seilhean D., Brice A., Feingold J., Meininger V., LeGuern E. Screening of OPTN in French familial amyotrophic lateral sclerosis. Neurobiol. Aging 2011, 32:e11-e13.
9. Rezaie T., Child A., Hitchings R., Brice G., Miller L., Coca-Prados M., Héon E., Krupin T., Ritch R., Kreutzer D., Crick R.P., Sarfarazi M. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002, 295:1077-1079.
10. Shaw C.E., Al-Chalabi A., Leigh N. Progress in the pathogenesis of amyotrophic lateral sclerosis. Curr. Neurol. Neurosci. Rep 2001, 1:69-76.
11. Smith, B.N., Newhouse, S., Shatunov, A., Vance, C., Topp, S., Johnson, L., Miller, J., Lee, Y., Troakes, C., Scott, K.M., Jones, A., Gray, I., Wright, J., Hortobagyi, T., Al-Sarraj, S., Rogelj, B., Powell, J., Lupton, M., Lovestone, S., Sapp, P.C., Weber, M., Nestor, P.J., Schelhaas, H.J., Asbroek, A.A., Silani, V., Gellera, C., Taroni, F., Ticozzi, N., Van den Berg, L., Veldink, J., Van Damme, P., Robberecht, W., Shaw, P.J., Kirby, J., Pall, H., Morrison, K.E., Morris, A., de Belleroche, J., Vianney de Jong, J.M., Baas, F., Andersen, P.M., Landers, J., Brown, R.H., Jr., Weale, M.E., Al-Chalabi, A., Shaw, C.E. The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder. Eur J Hum Genet. doi:ejhg201298[pii]10.1038/ejhg.2012.98.
12. Solski J.A., Williams K.L., Yang S., Nicholson G.A., Blair I.P. Mutation analysis of the optineurin gene in familial amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33:e9-e10.
13. Tumer Z., Bertelsen B., Gredal O., Magyari M., Nielsen K.C., Lucamp, Gronskov K., Brondum-Nielsen K. Novel heterozygous nonsense mutation of the OPTN gene segregating in a Danish family with ALS. Neurobiol. Aging 2011, 33:208.e1-208.e5.
14. van Blitterswijk M., van Vught P.W., van Es M.A., Schelhaas H.J., van der Kooi A.J., de Visser M., Veldink J.H., van den Berg L.H. Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients. Neurobiol. Aging 2012, 33:e1-e7.